APOC3

The need for an advanced understanding of lipidology structure and function in healthcare is growing.   Understanding lipoprotein function may provide valuable insights into an individual's lipid profile, aiding in the assessment of cardiovascular risk and guiding interventions above and beyond the standard lipid panel.  

ApoC3 is a lipoprotein primarily produced in the liver and intestines. Its role extends beyond lipid transport to include modulation of triglyceride-rich lipoprotein metabolism and regulation of lipolysis. 

Emerging research highlights its significance in cardiovascular health, insulin resistance, and metabolic syndrome.  [10.]

Understanding the intricate functions of ApoC3 and its relationships with other lipoproteins offers insights into the pathophysiology of various metabolic disorders and holds promise for developing targeted therapies to combat dyslipidemia and its associated complications. 

This article provides an overview of ApoC3, elucidating its structure, physiological roles, and current understandings of its clinical implications in health and disease.

Understanding ApoC3

What is ApoC3?

Apolipoprotein C3 (ApoC3) is a small protein component found primarily in triglyceride-rich lipoproteins like chylomicrons, very low-density lipoproteins (VLDL) and HDL particles in fed and fasting states.  [6.]  It is made in the liver and in the intestines.  

Function of ApoC3 in Lipid Metabolism and Cardiovascular Health

Overall, the combined functions of ApoC3 increase the time that triglyceride-rich components are in the bloodstream, and its presence on lipoprotein particles may increase their atherogenicity.  It is known to decrease lipolysis in circulation, reduce clearance of triglyceride-rich remnants, and stimulate VLDL secretion.  [6.]  

ApoC3 is classically thought of as an antagonist to ApoC2 and ApoE, which stimulate lipolysis and hepatic uptake of ApoB proteins.  [1.]

ApoC3 inhibits the lipolysis of triglyceride-rich lipoproteins mediated by lipoprotein lipase (LPL).  Its inhibition of LPL-mediated lipolysis occurs through multiple mechanisms, including displacing lipoproteins such as ApoE from the cell surface and inducing conformational changes in ApoE, thus hindering LPL activation. 

Additionally, ApoC3 has been implicated in increasing VLDL secretion, although the exact mechanisms in humans remain unclear.  [6.]

Despite its potential as a therapeutic target for dyslipidemia, further research is needed to elucidate its precise functions and therapeutic implications, particularly regarding VLDL secretion and ApoC3’s impact on liver health.

Clinical Significance of ApoC3 Levels

Current understanding of ApoC3's clinical implications centers on its role as an antagonist to ApoC2 and ApoE, hindering intravascular lipolysis by lipoprotein lipase (LPL) and liver clearance of apoB lipoproteins.  

Overall it is understood to be a marker for increased risk of cardiovascular disease and metabolic syndrome.  [10.]

This notion is supported by in vitro evidence demonstrating ApoC3's noncompetitive inhibition of LPL and its interference with the binding of ApoB lipoproteins to hepatic low-density lipoprotein receptors. 

Kinetic studies reveal that elevated plasma ApoC3 levels contribute significantly to hypertriglyceridemia in abdominally obese individuals, emphasizing its role in dyslipidemia.  [1., 13.]

Loss-of-function mutations in ApoC3 have been associated with reduced risks of ischemic vascular and heart diseases, highlighting its significance as a potential drug target for reducing cardiovascular risk. Pharmacological interventions targeting ApoC3 have shown promising results in reducing both plasma ApoC3 and triglyceride levels in humans. [1.]

However, the molecular mechanisms underlying ApoC3-induced hypertriglyceridemia are complex and warrant further investigation. 

ApoC3 Testing Options

Overview of ApoC3 Testing

ApoC3 testing involves assessing the levels of apolipoprotein C3 (ApoC3) in the bloodstream, typically through blood serum or plasma samples.  Venipuncture is commonly required.  This test is commonly done in research settings.  

Genetic testing to identify genetic polymorphisms of ApoC3 are also available.  

More commonly,  apolipoprotein testing including testing for ApoA1, ApoB, and ApoE, is available to provide additional insight into an individual’s cardiovascular risk profile.  

Natural Ways to Optimize ApoC3 Levels

Diet and lifestyle are the mainstays of good cardiometabolic health.  Certain supplements and medications may also be considered under the guidance of a licensed healthcare practitioner.  

Dietary Strategies

Diets Containing Fermented Dairy Products: diets containing fermented dairy products have been shown to promote healthy lipid outcomes and increase ApoA1 levels in particular.  [5., 9.]  

Foods Rich in Omega-3 Fatty Acids: Fatty fish (salmon, mackerel, sardines), flaxseeds, chia seeds, walnuts all have scientific evidence of efficacy in improving lipoprotein profiles and reducing cardiovascular disease risk.  [5., 9.]

Fiber-Rich Foods: Whole grains (oats, barley, quinoa), fruits (apples, berries, oranges), vegetables (broccoli, Brussels sprouts, carrots), legumes (beans, lentils) are all Mediterranean diet staples that have shown effectiveness in reducing cardiovascular disease risk.  [9.]

Avoid excess sugar: diets high in sugar are highly correlated with poor cardiometabolic health outcomes, as well as elevated triglycerides.  [5.]

Lifestyle Modifications

Regular Exercise: Aerobic activities (walking, jogging, swimming), strength training, yoga, tai chi may all promote cardiovascular health.  [5., 15.]

Smoking Cessation: Quitting smoking reduces oxidative stress and inflammation, contributing to improved lipid profiles.  [5.]

Stress Management: Techniques such as meditation, deep breathing exercises, yoga, and mindfulness may help lower stress levels and improve overall cardiovascular health,and in some cases may also have a positive effect on lipid profiles.  [11.]

Supplement Options 

Individuals should speak with their healthcare provider prior to initiating any supplement or medication therapies. 

Niacin (Vitamin B3): Niacin supplementation has been shown to improve HDL cholesterol and triglyceride levels.  [2., 8.]

Fish Oil: fish oil has been shown to reduce triglyceride levels and stimulate LPL activity.  [12.]

Order Lipoprotein Tests

Click here to compare and order tests for lipoprotein levels.

Click here to compare and order tests for genetic assessment of ApoC3.